349 related articles for article (PubMed ID: 28854973)
1. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG
BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
4. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.
Coleman S; Gilpin D; Kaplan FT; Houston A; Kaufman GJ; Cohen BM; Jones N; Tursi JP
J Hand Surg Am; 2014 Jan; 39(1):57-64. PubMed ID: 24315486
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
Gaston RG; Larsen SE; Pess GM; Coleman S; Dean B; Cohen BM; Kaufman GJ; Tursi JP; Hurst LC
J Hand Surg Am; 2015 Oct; 40(10):1963-71. PubMed ID: 26216077
[TBL] [Abstract][Full Text] [Related]
7. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
[TBL] [Abstract][Full Text] [Related]
8. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
[TBL] [Abstract][Full Text] [Related]
9. Pain Associated With Treatment of Dupuytren Contracture With Collagenase Clostridium histolyticum.
Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P; Fikri-Benbrahim N; Franco-Ferrando N; Peimer CA
J Hand Surg Am; 2017 Feb; 42(2):e109-e114. PubMed ID: 28160905
[TBL] [Abstract][Full Text] [Related]
10. Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study.
Coleman S; Gilpin D; Tursi J; Kaufman G; Jones N; Cohen B
BMC Musculoskelet Disord; 2012 Apr; 13():61. PubMed ID: 22540636
[TBL] [Abstract][Full Text] [Related]
11. Analysis of efficacy and safety of treatment with collagenase Clostridium histolyticum among subgroups of patients with Dupuytren contracture.
Raven RB; Kushner H; Nguyen D; Naam N; Curtin C
Ann Plast Surg; 2014 Sep; 73(3):286-90. PubMed ID: 23511746
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture.
McGrouther DA; Jenkins A; Brown S; Gerber RA; Szczypa P; Cohen B
Curr Med Res Opin; 2014 Apr; 30(4):733-9. PubMed ID: 24397625
[TBL] [Abstract][Full Text] [Related]
13. Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
Nayar SK; Pfisterer D; Ingari JV
Clin Orthop Surg; 2019 Sep; 11(3):332-336. PubMed ID: 31475055
[TBL] [Abstract][Full Text] [Related]
14. Dupuytren Cords Do Not Undergo Significant Histopathological Change After Collagenase Clostridium Histolyticum Injection.
Guo M; Yang K; Kock ND; Daley R; Dzwierzynski W; LoGiudice J; Hettinger P; Best C; Argenta A
Hand (N Y); 2023 Sep; 18(6):912-917. PubMed ID: 35081825
[No Abstract] [Full Text] [Related]
15. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N
J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613
[TBL] [Abstract][Full Text] [Related]
16. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Dupuytren Contractures After Collagenase Clostridium Histolyticum Injection: A Single-institution Experience.
Hwee YK; Park D; Vinas M; Litts C; Friedman D
Ann Plast Surg; 2017 Aug; 79(2):145-148. PubMed ID: 28604542
[TBL] [Abstract][Full Text] [Related]
19. Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture.
Kaplan FT
Drugs Today (Barc); 2011 Sep; 47(9):653-67. PubMed ID: 21971540
[TBL] [Abstract][Full Text] [Related]
20. Development of Collagenase Treatment for Dupuytren Disease.
Badalamente MA; Hurst LC
Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]